10-Q 1 a05-18524_110q.htm QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D)

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

(Mark One)

ý           Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 

For the period ended September 30, 2005.

 

o           Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 

Commission File Number:  0-20289

 

KEMET CORPORATION

(Exact name of registrant as specified in its charter)

 

DELAWARE

 

57-0923789

(State or other jurisdiction of
incorporation or organization)

 

(IRS Employer
Identification No.)

 

2835 KEMET WAY, SIMPSONVILLE, SOUTH CAROLINA 29681

(Address of principal executive offices, zip code)

 

(864) 963-6300

(Registrant’s telephone number, including area code)

 

Former name, former address and former fiscal year, if changed since last report:  N/A

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

YES  ý   NO  o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). ý   Yes  o  No

 

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act).   o  Yes  ý  No

 

Common Stock Outstanding at: September 30, 2005

 

Title of Each Class

 

Number of Shares Outstanding

Common Stock, $.01 Par Value

 

86,696,059

 

 



 

PART 1 - FINANCIAL INFORMATION

ITEM 1 - Financial Statements

 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheets

(Dollars in thousands except per share data)

(Unaudited)

 

 

 

September 30, 2005

 

March 31, 2005

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

36,135

 

$

26,898

 

Short-term investments

 

55,077

 

34,992

 

Accounts receivable, net

 

67,351

 

59,228

 

Inventories:

 

 

 

 

 

Raw materials and supplies

 

47,424

 

47,534

 

Work in process

 

40,086

 

41,862

 

Finished goods

 

36,478

 

44,539

 

Total inventories

 

123,988

 

133,935

 

Prepaid expenses and other current assets

 

12,286

 

9,571

 

Deferred income taxes

 

5,107

 

5,945

 

Total current assets

 

299,944

 

270,569

 

Property and equipment, net of accumulated depreciation of $604.7 million and $577.7 million as of September 30, 2005 and March 31, 2005, respectively

 

275,252

 

279,626

 

Property held for sale

 

4,676

 

2,326

 

Investments in U.S. government marketable securities

 

121,751

 

157,576

 

Investments in affiliates

 

590

 

682

 

Goodwill

 

30,471

 

30,471

 

Intangible assets, net

 

13,009

 

13,512

 

Other assets

 

3,383

 

3,335

 

Total assets

 

$

749,076

 

$

758,097

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Current portion of long-term debt

 

$

20,000

 

$

 

Accounts payable, trade

 

36,370

 

38,943

 

Accrued expenses

 

28,909

 

34,617

 

Income taxes payable

 

10,424

 

12,430

 

Total current liabilities

 

95,703

 

85,990

 

Long-term debt

 

80,000

 

100,000

 

Postretirement benefits and other non-current obligations

 

47,254

 

48,951

 

Deferred income taxes

 

7,174

 

7,953

 

Total liabilities

 

230,131

 

242,894

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Common stock, par value $0.01, authorized 300,000,000 shares issued 88,083,734 and 88,023,605 shares at September 30, 2005 and March 31, 2005, respectively

 

881

 

880

 

Additional paid-in capital

 

317,244

 

317,728

 

Retained earnings

 

221,971

 

220,846

 

Accumulated other comprehensive income/(loss)

 

4,428

 

2,669

 

Treasury stock, at cost (1,387,675 and 1,460,455 shares at September 30, 2005 and March 31, 2005, respectively)

 

(25,579

)

(26,920

)

Total stockholders’ equity

 

518,945

 

515,203

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

749,076

 

$

758,097

 

 

See accompanying notes to consolidated financial statements.

 

2



 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Statements of Operations

(Dollars in thousands except per share data)

(Unaudited)

 

 

 

Three months ending

 

Six months ending

 

 

 

September 30,

 

September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

116,608

 

$

106,022

 

$

230,712

 

$

228,405

 

 

 

 

 

 

 

 

 

 

 

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

97,463

 

102,773

 

192,453

 

202,896

 

(Gain)/loss on long-term supply contract

 

 

(11,139

)

 

(11,139

)

Selling, general and administrative

 

12,067

 

13,062

 

24,293

 

25,500

 

Research and development

 

6,008

 

6,637

 

12,225

 

13,375

 

Pension settlement charges

 

 

218

 

 

218

 

Restructuring charges

 

3,154

 

1,649

 

11,327

 

4,199

 

Total operating costs and expenses

 

118,692

 

113,200

 

240,298

 

235,049

 

 

 

 

 

 

 

 

 

 

 

Operating income/(loss)

 

(2,084

)

(7,178

)

(9,586

)

(6,644

)

 

 

 

 

 

 

 

 

 

 

Other (income)/expense:

 

 

 

 

 

 

 

 

 

Interest expense

 

1,639

 

1,579

 

3,307

 

3,202

 

Interest income

 

(1,402

)

(1,455

)

(2,727

)

(3,365

)

Other (income)/expense

 

(57

)

11

 

1,007

 

2,296

 

Total other (income)/expense

 

180

 

135

 

1,587

 

2,133

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before income taxes

 

(2,264

)

(7,313

)

(11,173

)

(8,777

)

 

 

 

 

 

 

 

 

 

 

Income tax (benefit)/expense

 

(354

)

152

 

(12,298

)

539

 

 

 

 

 

 

 

 

 

 

 

Net income/(loss)

 

$

(1,910

)

$

(7,465

)

$

1,125

 

$

(9,316

)

 

 

 

 

 

 

 

 

 

 

Net income/(loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.02

)

$

(0.09

)

$

0.01

 

$

(0.11

)

Diluted

 

$

(0.02

)

$

(0.09

)

$

0.01

 

$

(0.11

)

 

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

86,653,831

 

86,506,738

 

86,633,143

 

86,500,694

 

Diluted

 

86,653,831

 

86,506,738

 

86,696,023

 

86,500,694

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to consolidated financial statements.

 

3



 

KEMET CORPORATION AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Dollars in thousands)

(Unaudited)

 

 

 

Six months ended September 30,

 

 

 

2005

 

2004

 

Operating activities:

 

 

 

 

 

Net income/(loss)

 

$

1,125

 

$

(9,316

)

Adjustments to reconcile net income/(loss) to net cash provided by/(used in) operating activities:

 

 

 

 

 

Depreciation and amortization

 

20,584

 

22,372

 

Change in operating assets

 

(3,706

)

(10,427

)

Change in operating liabilities

 

(11,561

)

(19,928

)

Tax income/(expense) on stock options exercised

 

 

(212

)

Net cash provided by/(used in) operating activities

 

6,442

 

(17,511

)

 

 

 

 

 

 

Investing activities:

 

 

 

 

 

Purchases of short-term investments

 

 

(20,050

)

Proceeds from maturity of short-term investments

 

5,000

 

91

 

Additions to property and equipment

 

(13,701

)

(16,772

)

Purchases of U.S. government marketable securities

 

 

(104,071

)

Proceeds from maturity of long-term investments

 

10,000

 

5,000

 

Other

 

637

 

173

 

Net cash provided by/(used) in investing activities

 

1,936

 

(135,629

)

 

 

 

 

 

 

Financing activities:

 

 

 

 

 

Proceeds from sale of common stock to Employee Savings Plan

 

450

 

501

 

Proceeds from exercise of stock options

 

409

 

30

 

Net cash provided by/(used in) financing activities

 

859

 

531

 

 

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

 

9,237

 

(152,609

)

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

26,898

 

183,528

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

$

36,135

 

$

30,919

 

 

See accompanying notes to consolidated financial statements.

 

4



 

Note 1.  Basis of Financial Statement Preparation

 

The consolidated financial statements contained herein are unaudited and have been prepared from the books and records of KEMET Corporation and its Subsidiaries (“KEMET” or the “Company”).  In the opinion of management, the consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods.  The consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, therefore, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with U.S. generally accepted accounting principles.  Although the Company believes that the disclosures are adequate to make the information presented not misleading, it is suggested that these consolidated financial statements be read in conjunction with the audited financial statements and notes thereto included in the Company’s fiscal year ending March 31, 2005, Form 10-K.  Net sales and operating results for the six-month period ended September 30, 2005, are not necessarily indicative of the results to be expected for the full year.

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. In consolidation, all significant intercompany amounts and transactions have been eliminated.

 

Impact of Recently Issued Accounting Standards

 

In December 2004, the FASB issued SFAS No. 123 (revised 2005), “Share-Based Payment” (“SFAS No. 123(R)”).  SFAS No. 123(R) will require companies to measure all employee stock-based compensation awards using a fair value method and record such expense in its financial statements.  In addition, the adoption of SFAS No. 123(R) requires additional accounting and disclosure related to the income tax and cash flow effects resulting from share-based payment arrangements.  SFAS No. 123(R) is effective beginning as of the first annual reporting period beginning after June 15, 2005.  The Company is currently evaluating the impact that the adoption of SFAS No. 123(R) will have on its consolidated financial statements.  The cumulative effect of adoption, if any, will be measured and recognized in the consolidated statements of operations on the date of adoption.

 

In November 2004, the FASB issued SFAS No. 151, “Inventory Costs”.  This statement amends Accounting Research Bulletin (“ARB”) No. 43, Chapter 4, “Inventory Pricing,” and removes the “so abnormal” criterion that under certain circumstances could have led to the capitalization of these items.  SFAS No. 151 requires that idle facility expense, excess spoilage, double freight and rehandling costs be recognized as current period charges regardless of whether they meet the criterion of “so abnormal” as defined in ARB No. 43.  SFAS No. 151 also requires that allocation of fixed production overhead expenses to the costs of conversion be based on the normal capacity of the production facilities.  SFAS No. 151 is effective for all fiscal years beginning after June 15, 2005.  The Company is currently evaluating the impact that the adoption of SFAS No. 151 will have on its consolidated financial statements.

 

In March 2005, the FASB issued FASB Interpretation No. 47. FASB Interpretation No. 47 clarifies the term “asset retirement obligation” as used in SFAS No. 143 “Accounting for Asset Retirement Obligations.” This guidance requires an entity to record a liability for the fair value of a conditional asset retirement obligation if the fair value of the liability can be reasonably estimated. This interpretation is effective no later than the end of the fiscal year ending after December 15, 2005, and is not expected to have an impact on the consolidated financial statements of the Company.

 

In May 2005, the FASB issued SFAS No. 154, “Accounting Changes and Error Corrections”.  This statement replaces APB Opinion No. 20 and FASB Statement No. 3 and changes the requirements for the accounting for and reporting of a change in accounting principle.  In addition, SFAS No. 154 requires retrospective application to prior periods’ financial statements of changes in accounting principle.  SFAS No. 154 is effective for all fiscal years beginning after December 15, 2005.  The Company does not believe that the adoption of SFAS No. 154 will have a material impact on its consolidated financial statements.

 

Stock-based Compensation

 

The Company applies the intrinsic value-based method of accounting prescribed by Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees,” and its related interpretations in accounting for stock options.  As such, compensation expense would be recorded on the date of grant only if the current market price of the underlying stock exceeded the exercise price.  The Company has elected the “disclosure only” provisions of SFAS No. 123, “Accounting for Stock-Based Compensation,” which provide pro forma disclosure of earnings as if stock compensation were recognized on a fair-value basis.

 

5



 

Had compensation costs for the Company’s three stock option plans been determined based on the fair value at the grant date for awards, consistent with the provisions of SFAS No. 123, the Company’s net income/(loss) and income/(loss) per share would have been different from the pro forma amounts indicated below (dollars in thousands except per share data):

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

September 30,

 

September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

Net income/(loss)

 

 

 

 

 

 

 

 

 

As reported

 

$

(1,910

)

$

(7,465

)

$

1,125

 

$

(9,316

)

Less stock-based compensation expense determined under fair-value-based methods, net of related tax effects

 

(1,529

)

(1,249

)

(2,679

)

(2,499

)

Pro forma net income/(loss)

 

$

(3,439

)

$

(8,714

)

$

(1,554

)

$

(11,815

)

Income/(loss) per share:

 

 

 

 

 

 

 

 

 

Basic

As reported

 

$

(0.02

)

$

(0.09

)

$

0.01

 

$

(0.11

)

 

Pro forma

 

$

(0.04

)

$

(0.10

)

$

(0.02

)

$

(0.14

)

 

 

 

 

 

 

 

 

 

 

 

Diluted

As reported

 

$

(0.02

)

$

(0.09

)

$

0.01

 

$

(0.11

)

 

Pro forma

 

$

(0.04

)

$

(0.10

)

$

(0.02

)

$

(0.14

)

 

The pro forma amounts indicated above recognize compensation expense on a straight-line basis over the vesting period of the grant.  The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions for option grants issued during the three and six month periods ended September 30, 2005: expected life of 5 years; a risk-free interest rate of 3.63%; expected volatility of 49.1%; dividend yield of 0.0%; and fair value of $3.21.  The weighted-average assumptions for option grants issued during the three and six month periods ended September 30, 2004 include expected life of 5 years; a risk-free interest rate of 0.91%; expected volatility of 54.5%; dividend yield of 0.0%; and fair value of $7.02.

 

Revenue Recognition

 

Revenue is recognized from sales when a product is shipped and title has transferred.  The Company recognizes revenue only when all of the following criteria are met:  (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the seller’s price to the buyer is fixed or determinable, and (4) collectibility is reasonably assured.

 

A portion of sales is related to products designed to meet customer specific requirements.  These products typically have stricter tolerances making them useful to the specific customer requesting the product and to customers with similar or less stringent requirements.  Products with customer specific requirements are tested and approved by the customer before the Company mass produces and ships the product.  The Company recognizes revenue at shipment as the sales terms for products produced with customer specific requirements do not contain a final customer acceptance provision or other provisions that are unique and would otherwise allow the customer different acceptance rights.

 

A portion of sales is made to distributors under agreements allowing certain rights of return and price protection on unsold merchandise held by distributors.  The Company’s distributor policy includes inventory price protection and “ship-from-stock and debit” (“SFSD”) programs common in the industry.

 

The price protection policy protects the value of the distributors’ inventory in the event the Company reduces its published selling price to distributors.  This program allows the distributor to debit the Company for the difference between KEMET’s list price and the lower authorized price for specific parts.  The Company establishes price protection reserves on specific parts residing in distributors’ inventories in the period that the price protection is formally authorized by management.  The distributors also have the right to return to KEMET a certain portion of the purchased inventory, which, in general, will not exceed 5% of their rolling twelve month purchases.  KEMET estimates future returns based on historical patterns of the distributors and records an allowance on the Consolidated Balance Sheets.

 

6



 

The SFSD program provides a mechanism for the distributor to meet a competitive price after obtaining authorization from the local Company sales office.  This program allows the distributor to ship its higher-priced inventory and debit the Company for the

difference between KEMET’s list price and the lower authorized price for that specific transaction.  The Company establishes reserves for its SFSD program based primarily on actual inventory levels of certain distributor customers.  The actual inventory levels at these distributors comprise 91% - 95% of the total global distributor inventory.  The remaining 5% to 9% is estimated based on actual distributor inventory and current sales trends.  Management analyzes historical SFSD activity to determine the SFSD exposure on the global distributor inventory at the balance sheet date.  Should the distributors increase inventory levels, the estimate of the inventory at the distributors for the remaining 5% to 9% could be estimated at an incorrect amount.  However, the Company believes that the difference between the estimate and the ultimate actual amount would be immaterial.

 

The establishment of these reserves is recognized as a component of the line item Net sales on the Consolidated Statements of Operations, while the associated reserves are included in the line item Accounts receivable on the Consolidated Balance Sheets.

 

The Company provides a limited warranty to its customers that the products meet certain specifications.  The warranty period is generally limited to one year, and the Company’s liability under the warranty is generally limited to a replacement of the product or refund of the purchase price of the product.  Warranty costs as a percentage of net sales were less than 1% for the years ending March 31, 2005, 2004, 2003, and for the three and six months ending September 30, 2005 and 2004.  The Company recognizes warranty costs when identified.

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates, assumptions, and judgments. Estimates and assumptions are based on historical data and other assumptions that management believes are reasonable in the circumstances. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. In addition, they affect the reported amounts of revenues and expenses during the reporting period.

 

The Company’s judgments are based on management’s assessment as to the effect certain estimates, assumptions, or future trends or events may have on the financial condition and results of operations reported in KEMET’s unaudited consolidated financial statements. It is important that readers of these unaudited financial statements understand that actual results could differ from these estimates, assumptions, and judgments.

 

Note 2.  Reconciliation of basic income/(loss) per common share

 

In accordance with FASB Statement No. 128, “Earnings per Share”, the Company has included the following table presenting a reconciliation of basic EPS to diluted EPS fully displaying the effect of dilutive securities.

 

Computation of Basic and Diluted Income/(Loss) Per Share

(Dollars in thousands expect per share data)

 

 

 

For the three months ended September 30,

 

 

 

2005

 

2004

 

 

 

Loss

 

Shares

 

Per Share

 

Loss

 

Shares

 

Per Share

 

 

 

(numerator)

 

(denominator)

 

Amount

 

(numerator)

 

(denominator)

 

Amount

 

Basic EPS

 

$

(1,910

)

86,653,831

 

$

(0.02

)

$

(7,465

)

86,506,738

 

$

(0.09

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

 

 

 

 

 

 

Diluted EPS

 

$

(1,910

)

86,653,831

 

$

(0.02

)

$

(7,465

)

86,506,738

 

$

(0.09

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7



 

 

 

For the six months ended September 30,

 

 

 

2005

 

2004

 

 

 

Income

 

Shares

 

Per Share

 

Loss

 

Shares

 

Per Share

 

 

 

(numerator)

 

(denominator)

 

Amount

 

(numerator)

 

(denominator)

 

Amount

 

Basic EPS

 

$

1,125

 

86,633,143

 

$

0.01

 

$

(9,316

)

86,500,694

 

$

(0.11

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

 

62,880

 

 

 

 

 

Diluted EPS

 

$

1,125

 

86,696,023

 

$

0.01

 

$

(9,316

)

86,500,694

 

$

(0.11

)

 

The three months ended September 30, 2005, excluded potentially dilutive securities of approximately 3,387,500 because the effect would have been anti-dilutive.  The three and six months ended September 30, 2004, excluded potentially dilutive securities of approximately 4,311,370 and 4,311,797, respectively, in the computations of diluted income/(loss) per share because the effect would have been anti-dilutive.

 

Note 3. Derivatives and Hedging

 

The Company uses certain derivative financial instruments to reduce exposures to volatility of foreign currencies and commodities impacting the costs of its products.

 

Hedging Foreign Currencies

 

Certain operating expenses at the Company’s Mexican facilities are paid in Mexican pesos. In order to hedge these forecasted cash flows, management purchases forward contracts to buy Mexican pesos for periods and amounts consistent with the related underlying cash flow exposures. These contracts are designated as hedges at inception and monitored for effectiveness on a routine basis. At September 30, 2005 and March 31, 2005, the Company had outstanding forward exchange contracts that mature within approximately six months and twelve months, respectively, to purchase Mexican pesos with notional amounts of $30.8 million and $60.9 million, respectively.  The fair values of these contracts totaled $3.6 million and $3.1 million at September 30, 2005 and March 31, 2005, respectively, and are recorded as a derivative asset on the Company’s Consolidated Balance Sheets under Prepaid expenses and other current assets. During the next twelve months, it is estimated that approximately $3.6 million of the gain on these contracts will be recorded to cost of goods sold. The impact of the changes in fair values of these contracts resulted in accumulated other comprehensive income/(loss) (“AOCI/(L)”), net of taxes, of $(1.3) million and $0.5 million for the three and six month periods ended September 30, 2005, respectively.  The impact of the changes in fair values of these contracts resulted in AOCI/(L), net of taxes, of $1.2 million and $0.7 million for the three and six month periods ended September 30, 2004, respectively.

 

Certain sales are made in euros. In order to hedge these forecasted cash flows, management purchases forward contracts to sell euros for periods and amounts consistent with the related underlying cash flow exposures. These contracts are designated as hedges at inception and monitored for effectiveness on a routine basis. At September 30, 2005 and March 31, 2005, the Company had no outstanding euro forward exchange contracts.  The changes in fair value of these contracts resulted in AOCI/(L), net of taxes, of $(0.1) million and $0.3 million for the three and six month periods ended September, 30, 2004. respectively.

 

Changes in the derivatives’ fair values are deferred and recorded as a component of AOCI/(L) until the underlying transaction is recorded. When the hedged item affects income, gains or losses are reclassified from AOCI/(L) to the Consolidated Statements of Operations as Cost of goods sold for forward contracts to purchase Mexican pesos and as Net sales for forward contracts to sell euros. Any ineffectiveness, if material, in the Company’s hedging relationships is recognized immediately as a loss.

 

The Company formally documents all relationships between hedging instruments and hedged items, as well as risk management objectives and strategies for undertaking various hedge transactions.

 

8



 

Interest Rate Swaps

 

In August 2003, the Company entered into an interest rate swap contract (the “Swap”) which effectively converted its $100 million aggregate principal amount of 6.66% senior notes to floating rate debt adjusted semi-annually based on six-month LIBOR plus 3.35%. In October 2004, this contract was terminated for a $0.1 million gain and was recognized in other income for the fiscal year ended March 31, 2005. The fair value of the Swap, based upon market estimates provided by the counterparties, was approximately $0.5 million at September 30, 2004, and was recorded as a derivative liability on the Company’s Consolidated Balance Sheets under Prepaid expenses and other current assets. The change in fair value of this derivative instrument resulted in other income/(expense) of $1.1 million and $(1.2) million for the three and six month periods ended September 30, 2004, respectively.

 

Note 4. Restructuring charges

 

In July 2003, KEMET announced the Enhanced Strategic Plan (the “Plan”) which consisted of reorganizing its operations around the world, resulting in the location of virtually all of its production in low cost regions to be completed in mid fiscal year 2006.  This relocation allows KEMET access to key customers, access to key technical resources and knowledge, and access to available low-cost resources.  KEMET estimates it will incur special charges of approximately $42 million ($39 million disclosed in previous filings) over the period of the reorganization related to the movement of manufacturing operations to low-cost facilities in Mexico and China.  As of September 30, 2005, cumulative restructuring costs incurred totaled approximately $39.6 million.  Costs related to this movement of manufacturing operations are shown as manufacturing relocations in the chart below.

 

A reconciliation of the beginning and ending liability balances for restructuring charges included in the liabilities section of the Consolidated Balance Sheets for the periods ended September 30, 2005 and 2004 is shown below (dollars in thousands):

 

 

 

Three months ended September 30, 2005

 

Three months ended September 30, 2004

 

 

 

Personnel

 

Manufacturing

 

Termination

 

Personnel

 

Manufacturing

 

 

 

Reductions

 

Relocations

 

of a Contract

 

Reductions

 

Relocations

 

Beginning of period

 

$

6,513

 

$

 

$

839

 

$

6,577

 

$

 

Costs charged to expense

 

 

3,154

 

 

 

1,649

 

Costs paid or settled

 

(2,722

)

(3,154

)

(16

)

(535

)

(1,649

)

End of period

 

$

3,791

 

$

 

$

823

 

$

6,042

 

$

 

 

 

 

Six months ended September 30, 2005

 

Six months ended September 30, 2004

 

 

 

Personnel

 

Manufacturing

 

Termination

 

Personnel

 

Manufacturing

 

 

 

Reductions

 

Relocations

 

of a Contract

 

Reductions

 

Relocations

 

Beginning of period

 

$

6,794

 

$

 

$

 

$

7,177

 

$

 

Costs charged to expense

 

4,851

 

5,637

 

839

 

 

4,199

 

Costs paid or settled

 

(7,854

)

(5,637

)

(16

)

(1,135

)

(4,199

)

End of period

 

$

3,791

 

$

 

$

823

 

$

6,042

 

$

 

 

Manufacturing relocation costs are expensed as actually incurred, therefore no liability is recorded in the Consolidated Balance Sheets for these costs.  Costs charged to expense are aggregated in the Consolidated Statements of Operations line, Restructuring charges.

 

Personnel reductions – During June 2005, the Company announced a reduction in force effecting 138 people in the U.S., Mexico and Europe.  In conjunction with this announcement, the Company recognized a charge of $5.2 million during the quarter ending June 30, 2005.  In addition, the Company reversed $0.3 million related to unused restructuring accruals during the quarter ending June 30, 2005.

 

Manufacturing relocations – During the first six months ending September 30, 2005 and 2004, the Company incurred expenses of $5.6 million and $4.2 million, respectively.  These costs are related to the Plan.  All costs are expensed as incurred.

 

Termination of a contract – The Company recognized a charge of $0.8 million for the early termination of a contract during the first quarter ending June 30, 2006 related to a future plant closure.

 

9



 

Note 5. Other Postretirement Benefit Plans

 

The Company provides health care and life insurance benefits for certain retired employees who reach retirement age while working for the Company.  The components of the expense for postretirement medical and life insurance benefits are as follows (dollars in thousands):

 

 

 

Three months ended

 

Six months ended

 

 

 

September 30,

 

September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 

 

 

 

 

 

 

 

 

Service cost

 

$

152

 

$

222

 

$

304

 

$

532

 

Interest cost

 

460

 

740

 

920

 

1,582

 

Amortization of actuarial (gain)/loss

 

(404

)

45

 

(808

)

179

 

Total net periodic benefits costs

 

$

208

 

$

1,007

 

$

416

 

$

2,293

 

 

The Company expects to make no contributions to fund plan assets in fiscal year 2006 as the Company’s policy is to pay benefits as costs are incurred.  However, the Company estimates its benefits payments in fiscal year 2006 will be approximately $2.1 million.  Management is responsible for determining the cost of benefits for this plan.  Management considered a number of factors, and consulted with an actuarial firm, when determining this cost.

 

Note 6. Investments

 

Investments consist of debt securities as well as equity securities of public and privately-held companies.  The debt securities, which consist of U.S. government marketable securities, are classified as held-to-maturity securities, mature in one-month to five years, and are carried at amortized cost.  The effect of amortizing these securities is recorded as interest income.

 

The Company’s equity investments in public companies are classified as available-for-sale securities and are carried at fair value with adjustments recorded net of tax in stockholders’ equity.  The available-for-sale securities are intended to be held for an indefinite period but may be sold in response to unexpected future events.  The Company has an equity investment with less than 20% ownership interest in a privately-held company.  The Company does not have the ability to exercise significant influence and the investment is accounted for under the cost method.

 

On a periodic basis, the Company reviews the market values of its equity investment classified as available-for-sale securities and the carrying value of its equity investment carried at cost for the purpose of identifying “other-than-temporary” declines in market value and carrying value, respectively, as defined in EITF 03-1.   In June 2005, the Company reassessed its available-for-sale investment and determined that its value had declined on an “other than temporary” basis.  Accordingly, the Company recorded an after-tax adjustment of $0.6 million, which was included as Other(income)/ expense on the Consolidated Statement of Operations for the six month period ending September 30, 2005.  In September 2005, the Company evaluated its available-for-sale investment and determined that a further “other-than-temporary” decline did not exist.  The Company will continue to monitor the available-for-sale equity investment for potential future impairments.

 

A summary of the components and carrying values of investments on the Consolidated Balance Sheets is as follows (dollars in thousands):

 

 

 

September 30, 2005

 

March 31, 2005

 

Short-term investments

 

$

55,077

 

$

34,992

 

Equity investments:

 

 

 

 

 

Available-for-sale

 

471

 

563

 

Cost

 

119

 

119

 

U.S. government marketable securities

 

121,751

 

157,576

 

 

 

$

177,418

 

$

193,250

 

 

Short-term investments consist primarily of U.S. government securities.  Recorded value approximates fair value at September 30, 2005 and March 31, 2005.

 

10



 

Note 7.  Supply Contracts

 

The Company has renegotiated the tantalum supply agreement with Cabot Corporation that extends through calendar year 2006.  A reconciliation of the beginning and ending balance included in the liabilities section of the Consolidated Balance Sheets is as follows (dollars in thousands):

 

 

 

Inventory Supply Agreement

 

 

 

Six months ended

 

Twelve months ended

 

 

 

September 30, 2005

 

March 31, 2005

 

Beginning of period

 

$

5,483

 

$

24,275

 

Liability reduction

 

 

(11,767

)

Costs paid or settled

 

(2,563

)

(7,025

)

End of period

 

$

2,920

 

$

5,483

 

 

During fiscal year 2005, the Company decreased its liability and recognized a gain of $11.8 million based on an amendment to the Cabot Corporation tantalum supply agreement.  As of September 30, 2005, the remaining purchase commitments for this contract are $0.8 million for calendar year 2005 and $11.6 million for calendar year 2006.

 

Note 8.  Accumulated Other Comprehensive Income/(Loss)

 

Comprehensive income/(loss) for the three and six months ended September 30, 2005 and 2004 include the following components (dollars in thousands):

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

September 30,

 

September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

Net income/(loss)

 

$

(1,910

)

$

(7,465

)

$

1,125

 

$

(9,316

)

Other comprehensive income/(loss), net of tax:

 

 

 

 

 

 

 

 

 

Currency forward contract gain/(loss)

 

(1,336

)

1,037

 

484

 

870

 

Unrealized securities gain/(loss)

 

217

 

914

 

694

 

838

 

Currency translation gain/(loss)

 

565

 

28

 

581

 

142

 

Total other comprehensive income/(loss)

 

$

(2,464

)

$

(5,486

)

$

2,884

 

$

(7,466

)

 

The components of Accumulated other comprehensive income/(loss) on the Consolidated Balance Sheets are as follows (dollars in thousands):

 

 

 

September 30, 2005

 

March 31, 2005

 

Currency forward contract gain/(loss), net of tax

 

$

3,502

 

$

3,018

 

Unrealized securities gain/(loss), net of tax

 

217

 

(477

)

Currency translation gain/(loss)

 

709

 

128

 

Total accumulated other comprehensive income/(loss)

 

$

4,428

 

$

2,669

 

 

Note 9.  Goodwill and Intangible Assets

 

In July 2001, the FASB issued Statement of Financial Accounting Standards No. 141, “Business Combinations” (SFAS No. 141), and Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets” (SFAS No. 142). Statement No. 141 requires that the purchase method of accounting be used for all business combinations initiated after June 30, 2001. SFAS No. 141 also specifies criteria that intangible assets acquired in a purchase method business combination must meet in order to be recognized and reported apart from goodwill. SFAS No. 142 requires that goodwill and intangible assets with indefinite useful lives no longer be amortized, but instead be tested for impairment. In addition, any unamortized negative goodwill must be written off at the date of adoption. SFAS No. 142 was effective for fiscal years beginning after December 15, 2001, and was adopted by the Company effective April 1, 2002.

 

In connection with the adoption of SFAS No. 142, the Company completed impairment tests of its goodwill and other identifiable intangible assets including indefinite-lived trademarks. No impairment of goodwill or intangible assets was noted.

 

11



 

For purposes of determining the fair value of its trademarks, the Company utilizes a discounted cash flow model which considers the costs of royalties in the absence of trademarks owned by the Company.  Based upon the Company’s analysis of legal, regulatory, contractual, competitive and economic factors, the Company deemed that trademarks, which consist of the KEMET trade name and logo, have an indefinite useful life because they are expected to contribute to cash flows indefinitely.

 

The Company’s goodwill is tested for impairment at least on an annual basis. The impairment test involves a comparison of the fair value of its reporting unit as defined under SFAS No. 142, with carrying amounts. If the reporting unit’s aggregated carrying amount exceeds its fair value, then an indication exists that the reporting unit’s goodwill may be impaired. The impairment to be recognized is measured by the amount by which the carrying value of the reporting unit being measured exceeds its fair value, up to the total amount of its assets. The Company determined fair value based on a market approach which incorporates quoted market prices of the Company’s common stock and the premiums offered to obtain controlling interest for companies in the electronics industry.

 

KEMET performs its impairment test during the first quarter of each fiscal year and when otherwise warranted. KEMET performed this impairment test in the quarters ended June 30, 2005 and 2004 and concluded no goodwill impairment existed.

 

The Company performs the impairment test on the goodwill of The Forest Electric Company (“FELCO”) subsidiary on an annual basis in the third fiscal quarter or from time to time when necessary.  At March 31, 2005, there was no impairment of the FELCO goodwill.

 

The following chart highlights the Company’s goodwill and intangible assets (dollars in thousands):

 

The expected amortization expense for the fiscal years ending March 31, 2006, 2007, 2008, 2009, and 2010 is $1,005, $974, $943, $588, and $475, respectively.

 

 

 

September 30, 2005

 

March 31, 2005

 

 

 

Carrying

 

Accumulated

 

Carrying

 

Accumulated

 

 

 

Amount

 

Amortization

 

Amount

 

Amortization

 

Unamortized intangibles:

 

 

 

 

 

 

 

 

 

Goodwill

 

$

30,471

 

$

 

$

30,471

 

$

 

Trademarks

 

7,181

 

 

7,181

 

 

Unamortized intangibles

 

37,652

 

 

37,652

 

 

Amortized intangibles:

 

 

 

 

 

 

 

 

 

Patents and technology – 5-25 Years

 

14,655

 

9,001

 

14,655

 

8,549

 

Other – 8-10 Years

 

914

 

740

 

914

 

689

 

Amortized intangibles

 

15,569

 

9,741

 

15,569

 

9,238

 

Total goodwill and intangibles

 

$

53,221

 

$

9,741

 

$

53,221

 

$

9,238

 

 

Note 10.  Income Taxes

 

During the quarter ending September 30, 2005, the Mexican subsidiary received a ruling from the Hacienda (Mexican tax authority) related to an advance pricing agreement rate for fiscal years 2000 through 2002.  This ruling resulted in the reversal of $0.7 million in tax contingencies not previously recognized.

 

During the six months ended September 30, 2005, the Company recognized a tax benefit based on the reversal of $12.1 million relating to the finalization of an Internal Revenue Service examination for the fiscal years 1997 through 2003.

 

Note 11.  Segment Information

 

Under SFAS No. 131, “Disclosure about Segments of an Enterprise and Related Information”, the Company has only one reporting segment, which is passive components.  These passive components consists primarily of two product lines based on method of attachment: surface mount and leaded.  Net sales by product line are presented below (dollars in thousands):

 

 

 

Three months ended

 

Six months ended

 

 

 

September 30,

 

September 30,

 

 

 

2005

 

2004

 

2005

 

2004

 

Surface mount

 

$

97,508

 

$

86,492

 

$

191,442

 

$

185,726

 

Leaded

 

19,100

 

19,530

 

39,270

 

42,679

 

Net sales

 

$

116,608

 

$

106,022

 

$

230,712

 

$

228,405

 

 

12



 

Note 12.  Concentrations of Risks

 

Sales and Credit Risk

 

The Company sells to customers located throughout the United States and the world.  Credit evaluations of its customers’ financial condition are performed periodically, and the Company generally does not require collateral from its customers.  In October 2005, a customer of the Company filed for protection under Chapter 11 of the U.S. Bankruptcy Code.  At the time of the filing, the Company had open trade receivables due from the customer of $0.9 million.  Accordingly, the Company has provided a allowance for doubtful accounts of $0.3 million to account for any potential write-off of the open trade receivables.  The Company will continue to monitor the situation during subsequent quarters to determine if additional amounts will be deemed to be uncollectible.

 

Electronics distributors are an important distribution channel in the electronics industry and accounted for approximately 52%, 51% and 43% of the Company’s net sales in fiscal years 2005, 2004, and 2003, respectively.   For the six months ended September 30, 2005, sales to electronics distributors accounted for approximately 56% of the Company’s net sales.  For the six months ended September 30, 2004, sales to electronics distributors accounted for approximately 53% of the Company’s net sales.  As a result of the Company’s concentration of sales to electronics distributors, Company may experience fluctuations in its operating results as electronics distributors experience fluctuations in end-market demand or adjust their inventory stocking levels.

 

At September 30, 2005 and March 31, 2005, no customer accounted for more than 10% of the Company’s accounts receivable balance.

 

Employees

 

As of September 30, 2005, KEMET had approximately 8,600 employees, of whom approximately 1,100 were located in the United States, approximately 6,600 were located in Mexico, approximately 800 were located in China, and the remainder were primarily located in the Company’s non-U.S. sales offices.  The Company believes that its future success will depend in part on its ability to recruit, retain, and motivate qualified personnel at all levels of the Company.  The Company has approximately 4,700 hourly employees in Mexico represented by labor unions.  The Company has not experienced any major work stoppages and considers its relations with its employees to be good.

 

Note 13.  Property Held for Sale

 

As a result of moving manufacturing operations from the U.S. to low-cost facilities in Mexico and China, two of the manufacturing facilities located in the U.S. are no longer in use and are held for sale according to SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets”.  One manufacturing facility was placed for sale in fiscal year 2005 while the second manufacturing facility was placed for sale during the second quarter ending September 30, 2005.  The carrying value of these facilities at September 30, 2005 is $4.7 million and is separately presented in the Property held for sale line on the Consolidated Balance Sheets.  For the six months ended September 30, 2005, no gains or losses were recognized on these facilities as their fair value is believed to approximate carrying value based on an external appraisal.  On a quarterly basis, management has reviewed these valuations for indications of impairment.  A third facility has been placed for sale in the third quarter ending December 31, 2005.  The fair value of this facility is expected to approximate the carrying value.

 

Note 14.  Subsequent Events

 

In October 2005, the Company announced that it was in advanced negotiations with EPCOS AG with respect to acquiring the Tantalum Capacitor Business Unit of EPCOS.  The potential transaction is subject to completion of definitive documentation, as well as completion of due diligence procedures.  If final terms are reached, KEMET expects the transaction will be completed in the first quarter of calendar year 2006.

 

In October 2005, a customer of the Company filed for protection under Chapter 11 of the U.S. Bankruptcy Code.  At the time of the filing, the Company had open trade receivables due from the customer of $915 thousand.  Accordingly, the Company has provided a allowance for doubtful accounts of $250 thousand to account for any potential write-off of the open trade receivables.  The Company will continue to monitor the situation during subsequent quarters to determine if additional amounts will be deemed to be uncollectible.

 

13



 

On October 25, 2005, the Company announced the restructuring of its Fountain Inn, South Carolina Ceramics manufacturing and Innovation Center.  By the end of December 2005, the Company will relocate the remaining high-volume manufacturing to its Monterrey, Mexico facility.  As a result of this move, the Company will incur a charge related to a reduction-in-force of 34 people in the third fiscal quarter of 2006.  In addition, the Ceramics Innovation Center will relocate to the Simpsonville, South Carolina facility during the first fiscal quarter of 2007.

 

On October 31, 2005, the Company announced the resignation of James P. McClintock, the Head of Business Units and New Business Development (formerly President and Chief Operating Officer), effective as of November 1, 2005.

 

ITEM 2.  Management’s Discussion and Analysis of Results of Operations and Financial Condition

 

From time to time, information provided by the Company, including but not limited to statements in this report or other statements made by or on behalf of the Company, may contain “forward-looking” information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934.  Such statements involve a number of risks and uncertainties.  The Company’s actual results could differ materially from those discussed in the forward-looking statements.  The cautionary statements set forth in the Company’s 2005 Annual Report under the heading Safe Harbor Statement identify important factors that could cause actual results to differ materially from those in any forward-looking statements made by or on behalf of the Company.

 

ACCOUNTING POLICIES AND ESTIMATES

 

The following discussion and analysis of financial condition and results of operations are based on the Company’s unaudited consolidated financial statements included herein. The Company’s significant accounting policies are described in Note 1 to the consolidated financial statements in KEMET’s annual report on Form 10-K for the year ended March 31, 2005. The Company’s critical accounting policies are described under the caption “Critical Accounting Policies” in Item 7 of KEMET’s annual report on Form 10-K for the year ended March 31, 2005.

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates, assumptions, and judgments. Estimates and assumptions are based on historical data and other assumptions that management believes are reasonable in the circumstances. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. In addition, they affect the reported amounts of revenues and expenses during the reporting period.

 

The Company’s judgments are based on management’s assessment as to the effect certain estimates, assumptions, or future trends or events may have on the financial condition and results of operations reported in KEMET’s unaudited consolidated financial statements. It is important that readers of these unaudited financial statements understand that actual results could differ from these estimates, assumptions, and judgments.

 

Overview

 

KEMET is a leading manufacturer of tantalum, multilayer ceramic, and solid aluminum capacitors. Capacitors are electronic components that store, filter, and regulate electrical energy and current flow and are one of the essential passive components used on circuit boards. Virtually all electronic applications and products contain capacitors, including communication systems, data processing equipment, personal computers, cellular phones, automotive electronic systems, military and aerospace systems, and consumer electronics.

 

The Company’s business strategy is to generate revenues by being the preferred capacitor supplier to the world’s most successful electronics original equipment manufacturers, electronics manufacturing services providers, and electronics distributors. The Company reaches these customers through a direct sales force, as well as a limited number of manufacturing representatives, that call on customer locations around the world.

 

14



 

The Company’s business strategy is to generate revenues by being the preferred capacitor supplier to the world’s most successful electronics original equipment manufacturers, electronics manufacturing services providers, and electronics distributors. The Company reaches these customers through a direct sales force, as well as a limited number of manufacturing representatives, that call on customer locations around the world.

 

The Company manufactures capacitors in the United States, Mexico, and China.  Substantially all of the manufacturing in the United States is being relocated (see “Enhanced Strategic Plan”) to the Company’s lower-cost manufacturing facilities in Mexico and China. Production that remains in the U.S. will focus primarily on early-stage manufacturing of new products and other specialty products for which customers are predominantly located in North America.

 

The market for tantalum, ceramic, and aluminum capacitors is highly competitive. The capacitor industry is characterized by, among other factors, a long-term trend toward lower prices for capacitors, low transportation costs, and few import barriers. Competitive factors that influence the market for the Company’s products include product quality, customer service, technical innovation, pricing, and timely delivery. The Company believes that it competes favorably on the basis of each of these factors.

 

Enhanced Strategic Plan

 

In July 2003, KEMET announced its Enhanced Strategic Plan (the “Plan”) to enhance the Company’s position as a global leader in passive electronic technologies. KEMET believes that there have been profound changes in the competitive landscape of the electronics industry over the past several years. The Company listened closely to its customers’ description of their future directions, and is aligning KEMET’s future plans closely with their plans. Building on the Company’s foundation of success in being the preferred supplier to the world’s most successful electronics manufacturers and distributors, KEMET is adapting so as to continue to succeed in the new global environment.

 

KEMET’s strategy has three foundations:

 

Enhancing the Company’s position as the market leader in quality, delivery, and service through outstanding execution;

 

Having a global mindset, with an increased emphasis on growing KEMET’s presence in Asia; and

 

Accelerating the pace of innovations to broaden the Company’s product portfolio.

 

To execute the Plan, KEMET is in the process of reorganizing its operations around the world. Over the next three months, the remaining U.S. KEMET production facilities will be relocated based on access to key customers, access to key technical resources and knowledge, and availability of low-cost resources. KEMET estimates it will incur special charges of approximately $42 million (of which $39.6 million had been spent through September 30, 2005) over the period of the reorganization related to movement of manufacturing operations.

 

KEMET’s Global Presence

 

KEMET in the United States

 

KEMET’s corporate headquarters are expected to remain in Greenville, South Carolina, though individual functions will continue to evolve to support global activities in Asia, Europe, and North America, either from Greenville, South Carolina or through locations in appropriate parts of the world.

 

Substantially all manufacturing currently in the United States will continue to be relocated to the Company’s lower-cost manufacturing facilities in Mexico and China. Production that remains in the U.S. is expected to focus primarily on early-stage manufacturing of new products and other specialty products for which customers are predominantly located in North America.

 

To accelerate the pace of innovations, the KEMET Innovation Center was created. The primary objectives of the Innovation Center are to ensure the flow of new products and robust manufacturing processes that are expected to keep the Company at the forefront of its customers’ product designs, while enabling these products to be transferred rapidly to the most appropriate KEMET manufacturing location in the world for low-cost, high-volume production. The main campus of the KEMET Innovation Center is located in Simpsonville, South Carolina.

 

15



 

KEMET in Mexico

 

KEMET believes its Mexican operations are among the most cost efficient in the world, and they will continue to be the Company’s primary production facilities supporting North American and European customers. One of the strengths of KEMET Mexico is that it is truly a Mexican operation, including Mexican management and workers. These facilities will be responsible for maintaining KEMET’s traditional excellence in quality, service, and delivery, while driving costs down. The facilities in Victoria and Matamoros will remain focused primarily on tantalum capacitors, and the facilities in Monterrey will continue to focus on ceramic capacitors.

 

KEMET in China

 

In recent years, low production costs and proximity to large, growing markets have caused many of KEMET’s key customers to relocate production facilities to Asia, particularly China. KEMET has a well-established sales and logistics network in Asia to support its customers’ Asian operations. The Company’s initial China production facilities in Suzhou near Shanghai commenced shipments in October 2003. Like KEMET Mexico, the vision for KEMET China is to be a Chinese operation, with Chinese management and workers, to help achieve KEMET’s objective of being a global company. These facilities will be responsible for maintaining KEMET’s traditional excellence in quality, service, and delivery, while accelerating cost-reduction efforts and supporting efforts to grow the Company’s customer base in Asia.

 

KEMET in Europe

 

KEMET will maintain and enhance its strong European sales force, allowing KEMET to continue to meet the local preferences of European customers who remain an important focus for KEMET going forward.

 

Global Sales and Logistics

 

In recent years, it has become more complex to do business in the electronics industry. Market-leading electronics manufacturers have spread their facilities more globally. The growth of the electronics manufacturing services (EMS) industry has resulted in a more challenging supply chain. New Asian electronics manufacturers are emerging rapidly. The most successful business models in the electronics industry are based on tightly integrated supply chain logistics to drive down costs. KEMET’s well-developed global logistics infrastructure distinguishes it in the marketplace and will remain a hallmark of KEMET in meeting the needs of its global customers.

 

Subsequent Events

 

In October 2005, the Company announced that it was in advanced negotiations with EPCOS AG with respect to acquiring the Tantalum Capacitor Business Unit of EPCOS.  The potential transaction is subject to completion of definitive documentation, as well as completion of due diligence procedures.  If final terms are reached, KEMET expects the transaction will be completed in the first fiscal quarter of calendar year 2006.

 

In October 2005, a customer of the Company filed for protection under Chapter 11 of the U.S. Bankruptcy Code.  At the time of the filing, the Company had open trade receivables due from the customer of $915 thousand.  Accordingly, the Company has provided a allowance for doubtful accounts of $250 thousand to account for any potential write-off of the open trade receivables.  The Company will continue to monitor the situation during subsequent quarters to determine if additional amounts will deemed to be uncollectible.

 

On October 25, 2005, the Company announced the restructuring of its Fountain Inn, South Carolina Ceramics Production and Innovation Center.  By the end of December 2005, the Company will relocate the remaining high-volume manufacturing to its Monterrey, Mexico facility.  As a result of this move, the Company will incur a charge related to a reduction-in-force of 34 people in the third fiscal quarter of 2006.  In addition, the Ceramics Innovation Center will relocate to the Simpsonville, South Carolina facility during the first fiscal quarter of 2007.

 

On October 31, 2005, the Company announced the resignation of James P. McClintock, the Head of Business Units and New Business Development (formerly President and Chief Operating Officer), effective as of November 1, 2005.

 

16



 

Alliance with Taiyo Yuden

 

In September 2005, the Company announced a strategic alliance with Taiyo Yuden Co., Ltd through which the companies will work together utilizing their respective best practices in the areas of manufacturing, technology, marketing, and customer support expertise to better serve the industry, reduce costs, increase market share, and expand market penetration.  As a key feature of this alliance, each company will have the right to market and sell the other’s products, thus mutually expanding their product portfolio for both current and future customers.  Furthermore, the alliance is designed to combine the industry-leading product development and manufacturing strengths of Taiyo Yuden with KEMET’s industry-leading customer service and logistics, thereby bringing the combined strengths of both companies to the market.

 

The alliance is structured such that Taiyo Yuden and KEMET will continue to offer independent and competitive pricing to the industry.

 

Employees

 

As of September 30, 2005, KEMET had approximately 8,600 employees, of whom approximately 1,100 were located in the United States, approximately 6,600 were located in Mexico, approximately 800 were located in China, and the remainder were primarily located in the Company’s non-U.S. sales offices.  The Company believes that its future success will depend in part on its ability to recruit, retain, and motivate qualified personnel at all levels of the Company.  The Company has approximately 4,700 hourly employees in Mexico represented by labor unions.  The Company has not experienced any major work stoppages and considers its relations with its employees to be good.

 

RESULTS OF OPERATIONS

 

Recent Trend in Average Selling Prices

 

Average selling prices for the September 2005 quarter adjusted for changes in product mix, decreased by 3% to 4% as compared to average selling prices for the June 2005 quarter.

 

Comparison of the Three-Month Period Ended September 30, 2005, with the Three-Month Period Ended September 30, 2004

 

Net Sales

 

Net sales for the three months ended September 30, 2005, increased 10.0% to $116.6 million as compared to the same period last year.  The increase in net sales was attributable to higher volumes.  Unit volumes in the three-month period ended September 30, 2005 increased 15.8% as compared to the same period last year.  Mix-adjusted average selling prices for the September 2005 quarter decreased approximately 15.3% compared to average selling prices for the September 2004 quarter.

 

Net sales of surface-mount capacitors were 83.6% of net sales or $97.5 million for the three months ended September 30, 2005, compared to 81.6% of net sales or $86.5 million for the same period last year. Net sales of leaded capacitors were 16.4% of net sales or $19.1 million for the three months ended September 30, 2005, versus 18.4% of net sales or $19.5 million during the same period last year.

 

By region, 42.7% of net sales for the three months ended September 30, 2005 were to customers in North America, 40.8% were to Asia, and 16.5% were to Europe.  By region, 47.0% of net sales for the three months ended September 30, 2004 were to customers in North America, 34.0% were to Asia, and 19.0% were to Europe.

 

By channel, 55.8% of net sales for the three months ended September 30, 2005 were to distribution customers, 23.4% were to Electronic Manufacturing Services customers, and 20.8% were to Original Equipment Manufacturing customers.  By channel, 50.0% of net sales for the three months ended September 30, 2004 were to distribution customers, 27.0% were to Electronic Manufacturing Services customers, and 23.0% were to Original Equipment Manufacturing customers.

 

17



 

Cost of Sales

 

Cost of sales for the three months ended September 30, 2005, was $97.5 million, or 83.6% of net sales, as compared to $102.8 million, or 96.9% of net sales, for the same period last year The decline in cost of sales as a percentage of net sales was due to the reduction in depreciation expense in relation to the asset impairment taken during the fourth quarter of fiscal year 2005.  Partially offsetting this decline was continued average selling prices decreases.

 

Selling, General and Administrative Expenses

 

Selling, general, and administrative expenses (“SG&A”) for the three months ended September 30, 2005, were $12.1 million, or 10.3% of net sales, as compared to $13.1 million, or 12.3% of net sales for the same period last year. The decrease is due to the Company’s continuing cost reduction efforts in SG&A over the last twelve months.

 

Research and Development Expenses

 

Research and development expenses for the three months ended September 30, 2005, were $6.0 million, or 5.2% of net sales, as compared to $6.6 million, or 6.3% of net sales for the same period last year.  It is the Company’s intent to spend an amount equal to 5% of net sales dollars in the development of new products and technologies, such as organic polymer tantalum and high capacitance ceramic capacitor technologies.

 

Special Charges

 

The Company reports a measure entitled Special Charges.  These charges are considered items outside of normal operations, and it is the intent of KEMET to provide an alternative depiction of the operating results.  Since some of the items are not considered restructuring charges as defined by U.S. generally accepted accounting principles, the Company has provided the breakout of U.S. generally accepted accounting principles restructuring charges and those other charges and adjustments separately.

 

A summary of the special charges recognized in the quarters ended September 30, 2005 and 2004 is as follows (in millions):

 

 

 

Three months ended September 30,

 

 

 

2005

 

2004

 

 

 

 

 

 

 

Manufacturing relocation costs

 

$

3.2

 

$

1.6

 

 

 

 

 

 

 

Restructuring charges (1) 

 

3.2

 

1.6

 

 

 

 

 

 

 

(Gain)/loss on long-term supply contract (2) 

 

 

(11.1

)

Special charges/(benefits)

 

$

3.2

 

$

(9.5

)

 


(1)   Restructuring charges – These costs are included as a separate line item on the Consolidated Statements of Operations.

(2)   (Gain)/loss on long-term supply contract – This benefit is included as a separate line item on the Consolidated Statements of Operations.

 

Manufacturing relocation costs – The costs in this item relates to the aforementioned Enhanced Strategic Plan.  During the three month period ending September 30, 2005, the Company incurred costs of $3.2 million, which has been recorded as restructuring costs.  As of September 30, 2005, cumulative restructuring costs incurred as a result of manufacturing relocation and employee termination totaled approximately $39.6 million.  The remaining unspent amount should be incurred primarily in the next three months.  During the quarter ended September 30, 2004, the Company incurred costs of $1.6 million relating to manufacturing relocations.

 

(Gain)/loss on long-term supply contract – The Company recognized an $11.1 million gain in the second fiscal quarter 2005 to reflect the decrease in its liability as a result of an amended contract with Cabot Corporation.

 

18



 

Operating Income/(Loss)

 

Operating loss for the three months ended September 30, 2005, was $2.1 million, compared to an operating loss of $7.2 million for the quarter ended September 30, 2004. The improvement in the operating loss was primarily due to higher sales volumes, lower selling, general, and administrative costs and lower research and development costs offset by higher restructuring costs in the current quarter as well as the impact of lower average selling prices.  The impact of the cost reduction efforts of the Company have favorably affected cost of goods sold, selling, general, and administrative costs and research and development costs.

 

Other Income and Expense

 

Interest expense was slightly higher in the three months ending September 30, 2005 as compared to the comparable quarter in the prior year due to a portion on the interest cost being capitalized into inventory during the three month period ending September 30, 2004.

 

Interest income was lower in the three months ended September 30, 2005 versus the comparable period in the prior year primarily due to the Company’s lower investments in the second fiscal quarter 2006 versus the corresponding quarter of the preceding year.

 

Other (income)/expense improved in the three months ended September 30, 2005 versus the comparable period of the preceding year due to a foreign currency translation loss in the three month period ending September 30, 2004.

 

Income Taxes

 

The income tax benefit totaled $0.4 million for the three months ended September 30, 2005, compared to an income tax expense of $0.2 million for the three months ended September 30, 2004. The tax benefit is composed of a reversal of $0.7 million in prior tax contingencies which were not realized and $0.3 million in foreign income tax expense.

 

Management evaluates its tax assets and liabilities on a periodic basis and adjusts these balances on a timely basis as appropriate, based on certain estimates and assumptions and sufficient future taxable income to utilize its deferred tax benefits. If these estimates and related assumptions change in the future, the Company may be required to increase the value of the deferred tax liability, resulting in additional income tax expense.

 

Comparison of the Six-Month Period Ended September 30, 2005, with the Six-Month Period Ended September 30, 2004

 

Net Sales

 

Net sales for the six months ended September 30, 2005, increased 1.0% to $230.7 million as compared to the same period last year.  The increase in net sales was attributable to higher volumes.  Unit volumes in the six-month period ended September 30, 2005 increased 15.5% as compared to the same period last year.  Mix-adjusted average selling prices for the six month period ending September 2005 decreased approximately 17.1% compared to average selling prices for the six month period ending September 2004.

 

Net sales of surface-mount capacitors were 83.0% of net sales or $191.4 million for the six months ended September 30, 2005, compared to 81.3% of net sales or $185.7 million for the same period last year. Net sales of leaded capacitors were 17.0% of net sales or $39.3 million for the six months ended September 30, 2005, versus 18.7% of net sales or $42.7 million during the same period last year.  Unit volumes increased approximately 16.1% for surface-mount capacitors and decreased approximately 9.2% for leaded capacitors.

 

Cost of Sales

 

Cost of sales for the six months ended September 30, 2005, was $192.5 million, or 83.4% of net sales, as compared to $202.9 million, or 88.8% of net sales, for the same period last year.  The decline in cost of sales as a percentage of net sales was due to the reduction in depreciation expense in relation to the asset impairment taken during the fourth fiscal quarter of 2005.  Partially offsetting this decline was continued average selling price decreases.

 

19



 

Research and Development Expenses

 

Research and development expenses for the six months ended September 30, 2005, were $12.2 million, or 5.3% of net sales, as compared to $13.4 million, or 5.9% of net sales for the same period last year. It is the Company’s intent to spend approximately 5% of net sales dollars in the development of new products and technologies, such as organic polymer tantalum and high capacitance ceramic capacitor technologies.

 

Special Charges

 

The Company reports a measure entitled Special Charges.  These charges are considered items outside of normal operations, and it is the intent of KEMET to provide an alternative depiction of the operating results.  Since some of the items are not considered restructuring charges as defined by U.S. generally accepted accounting principles, the Company has provided the breakout of U.S. generally accepted accounting principles restructuring charges and those other charges and adjustments separately.

 

A summary of the special charges recognized in the six-month periods ended September 30, 2005 and 2004 is as follows (in millions):

 

 

 

Six months ending September 30,

 

 

 

2005

 

2004

 

 

 

 

 

 

 

Manufacturing relocation costs

 

$

5.6

 

$

4.2

 

Personnel reduction cost

 

5.2

 

 

Termination of contract

 

0.8

 

 

Reversal of previously recorded restructuring accrual

 

(0.3

)

 

Restructuring charges (1)

 

$

11.3

 

$

4.2

 

 

 

 

 

 

 

(Gain)/loss on long-term supply contract (2)

 

 

(11.1

)

Writedown of an investment in unconsolidated subsidiary (3)

 

0.6

 

 

Tax benefit not previously recognized (4)

 

(12.1

)

 

Special charges/(benefits), net

 

$

(0.2

)

$

(6.9

)

 


(1)   Restructuring charges – These costs are included as a separate line item on the Consolidated Statements of Operations.

(2)   (Gain)/loss on long-term supply contract – This benefit is included as a separate line item on the Consolidated Statements of Operations.

(3)   Writedown of an investment in unconsolidated subsidiary – These costs are included in Other (income)/expense on the Consolidated Statements of Operations.

(4)   Tax benefit not previously recognized – This benefit is included in Income tax expense/(benefit) on the Consolidated Statements of Operations.

 

Manufacturing relocation costs – The costs in this item relates to the aforementioned Enhanced Strategic Plan.  During the six-month period ending September 30, 2005, the Company incurred costs of $5.6 million, which has been recorded as restructuring costs.  During the quarter ended September 30, 2004, the Company incurred $4.2 million relating to manufacturing relocations.

 

Personnel reduction cost – In June 2005, the Company recognized a reduction in workforce in which 138 employees were terminated.  The employees were located in the U.S., Mexico and Europe.  In conjunction with this termination, the Company recognized a charge of $5.2 million to account for the severance costs.

 

Termination of a contract – In June 2005, the Company recognized a liability for a contract termination.  The contract is being terminated due to operations being relocated to other geographies.

 

Reversal of previously recorded restructuring accrual – During the quarter ending June 30, 2005, a portion of the restructuring charge recorded in March 2005 was deemed unnecessary due to the former Chief Executive Officer obtaining a position with another company.  Accordingly, the Company reversed the unused remaining accrual as an element of the first fiscal quarter 2006 restructuring charge.

 

(Gain)/loss on long-term supply contract – The Company recognized an $11.1 million gain in the second fiscal quarter 2005 to reflect the decrease in its liability as a result of an amended contract with Cabot Corporation.

 

20



 

Write-down on investment in unconsolidated subsidiary – During the first fiscal quarter 2006, the Company determined that the value of its investment in an unconsolidated subsidiary (Tantalum Australia NL) had decreased, and the decrease was deemed other-than-temporary.  Therefore, the Company recorded a charge in the first fiscal quarter 2006 of $0.6 million, net of tax.

 

Tax benefit not previously recognized – During the first fiscal quarter 2006, the Internal Revenue Service finalized the examination related to fiscal years 1997 through 2003.  This finalization resulted in the receipt of $9.8 million during the June 2005 quarter, and the reversal of a $12.1 million tax benefit not previously recognized.

 

Operating Income/(Loss)

 

Operating loss for the six months ended September 30, 2005, was $9.6 million, compared to an operating loss of $6.6 million for the six month period ended September 30, 2004. The operating loss for the six month period ending September 30, 2004 included an $11.1 million benefit relating to a gain on a long-term supply contract realized in the six month period ending September 30, 2004.  Without this benefit, the operating loss for the six month period ending September 2005 would have improved by 46.1% due to higher sales volumes, lower selling, general and administrative costs and lower research and development costs offset by higher restructuring costs in the six month period as well as the impact of lower average selling prices.

 

Other Income and Expense

 

Interest expense was slightly higher in the six months ending September 30, 2005 as compared to the comparable period in the prior year due to interest capitalization into inventory during the six month period ending September 30, 2004.

 

Interest income was lower in the six months ended September 30, 2005 versus the comparable period in the prior year primarily due to the Company’s lower investments during the six month period in 2006 versus the corresponding period.

 

Other (income)/expense improved in the six months ended September 30, 2005 versus the comparable period due to a charge of $1.2 million associated with the mark-to-market adjustment of an interest rate swap contract in the six month period ending September 30, 2004.

 

Income Taxes

 

The income tax benefit totaled $12.3 million for the six months ended September 30, 2005, compared to an income tax expense of $0.5 million for the six months ended September 30, 2004. The tax benefit is composed of a reversal of $12.1 million relating to the finalization of an Internal Revenue Service examination for the fiscal years 1997 through 2003 as well as $0.7 million reversal in other prior tax contingencies which were not realized and $0.5 million in foreign income tax expense.

 

Management evaluates its tax assets and liabilities on a periodic basis and adjusts these balances on a timely basis as appropriate, based on certain estimates and assumptions and sufficient future taxable income to utilize its deferred tax benefits. If these estimates and related assumptions change in the future, the Company may be required to increase the value of the deferred tax liability, resulting in additional income tax expense.

 

Liquidity and Capital Resources

 

The Company’s liquidity needs arise from working capital requirements, capital expenditures, and principal and interest payments on its indebtedness.  The Company intends to satisfy its liquidity requirements primarily with cash and cash equivalents provided by operations and the sale of short-term investments.

 

The Company increased cash and cash equivalents by $9.2 million during the six months ended September 30, 2005.  Cash was generated from operations, from finance activities, and from investing activities.  Each of these is discussed below:

 

21



 

Cash from Operating Activities

 

Cash flows from operating activities for the six months ended September 30, 2005, generated $6.4 million compared to an usage of $17.5 million in the prior year. The increase in cash from operating activities in the current period was primarily a result of cash received from a federal tax refund and related interest totaling $10.4 million and a $5.9 million reduction in inventory offset by increases in accounts receivable of $8.1 million, increases in prepaid expenses and other current assets of $2.7 million and decreases in accounts payable and accrued liabilities of $2.6 million and $5.5 million, respectively.  The increase in accounts receivable is due to high volumes of sales in the latter stages of second fiscal quarter 2006.  The increase in prepaid expenses and other current assets is due to an income tax receivable from fiscal years 2003 and 2004.  The decrease in accrued liabilities is due to the settlement of restructuring charges taken in previous quarters.

 

Cash from Investing Activities

 

Cash flows from investing activities for the six months ended September 30, 2005, generated $1.9 million compared to an usage of $135.6 million in the prior year. In the six months ended September 30, 2005, $5.0 million of short-term investments matured and $10.0 million of long-term investments matured.  Each of these maturing investments was converted into cash and cash equivalents which was offset by capital expenditures of $13.7 million.  In the six month period ended September 30, 2004, the uses of cash including the purchases of $104.1 million of long-term investments, purchases of $20.1 million of short-term investments, and capital expenditures of $16.8 million.

 

The Company currently estimates its capital expenditures for fiscal year 2006 to be approximately $25 million.

 

Cash from Financing Activities

 

Cash flows from financing activities for the six months ended September 30, 2005 and 2004, generated $0.9 million and $0.6 million, respectively.  In both periods, cash generated resulted primarily from stock transactions during the six month periods.

 

During the six months ended September 30, 2005, the Company’s indebtedness did not change. The Company was in compliance with the covenants under its $100 million long-term debt as of the most recent reporting period.  In May 2006, a principal payment of $20 million will be due and is therefore presented as the Current portion of long-term debt on the Consolidated Balance Sheet at September 30, 2005.

 

KEMET believes its financial position will permit the financing of its business needs and opportunities in an orderly manner. It is anticipated that ongoing operations will be financed primarily by internally generated funds and cash on hand.

 

Commitments

 

As of September 30, 2005, the Company had contractual obligations in the form of non-cancelable operating leases, long-term supply contracts for the purchase of tantalum powder and wire (see Note 7 to the consolidated financial statements), and debt, including interest payments, as follows (dollars in thousands):

 

 

 

Fiscal years ending March 31,

 

 

 

Remainder

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

of 2006

 

2007

 

2008

 

2009

 

2010

 

Thereafter

 

Total

 

Operating leases

 

$

1,666

 

$

2,392

 

$

1,856

 

$

1,136

 

$

612

 

$

1,866

 

$

9,528

 

Tantalum supply agreement

 

3,600

 

8,800

 

 

 

 

 

12,400

 

Debt

 

 

20,000

 

20,000

 

20,000

 

20,000

 

20,000

 

100,000

 

Interest payments

 

3,330

 

5,994

 

4,662

 

3,330

 

1,998

 

666

 

19,980

 

 

 

$

8,596

 

$

37,186

 

$

26,518

 

$

24,466

 

$

22,610

 

$

22,532

 

$

141,908

 

 

Impact of Recently Issued Accounting Standards

 

In December 2004, the FASB issued SFAS No. 123 (revised 2005), “Share-Based Payment” (“SFAS No. 123(R)”).  SFAS No. 123(R) will require companies to measure all employee stock-based compensation awards using a fair value method and record such expense in its financial statements.  In addition, the adoption of SFAS No. 123(R) requires additional accounting and disclosure related to the income tax and cash flow effects resulting from share-based payment arrangements.  SFAS No. 123(R) is effective beginning as of the annual reporting period beginning after June 15, 2005.  The Company is currently evaluating the impact that the adoption of SFAS No. 123(R) will have on its consolidated financial statements.  The cumulative effect of adoption, if any, will be measured and recognized in the consolidated statements of operations on the date of adoption.

 

22



 

In November 2004, the FASB issued SFAS No. 151, “Inventory Costs”.  This statement amends Accounting Research Bulletin (“ARB”) No. 43, Chapter 4, “Inventory Pricing,” and removes the “so abnormal” criterion that under certain circumstances could have led to the capitalization of these items.  SFAS No. 151 requires that idle facility expense, excess spoilage, double freight and rehandling costs be recognized as current period charges regardless of whether they meet the criterion of “so abnormal” as defined in ARB No. 43.  SFAS No. 151 also requires that allocation of fixed production overhead expenses to the costs of conversion be based on the normal capacity of the production facilities.  SFAS No. 151 is effective for all fiscal years beginning after June 15, 2005.  The Company is currently evaluating the impact that the adoption of SFAS No. 151 will have on its consolidated financial statements.

 

In March 2005, the FASB issued FASB Interpretation No. 47. FASB Interpretation No. 47 clarifies the term “asset retirement obligation” as used in SFAS No. 143 “Accounting for Asset Retirement Obligations.” This guidance requires an entity to record a liability for the fair value of a conditional asset retirement obligation if the fair value of the liability can be reasonably estimated. This interpretation is effective no later than the end of the fiscal year ending after December 15, 2005, and is not expected to have an impact on the consolidated financial statements of the Company.

 

In May 2005, the FASB issued SFAS No. 154, “Accounting Changes and Error Corrections”.  This statement replaces APB Opinion No. 20 and FASB Statement No. 3 and changes the requirements for the accounting for and reporting of a change in accounting principle.  In addition, SFAS No. 154 requires retrospective application to prior periods’ financial statements of changes in accounting principle.  SFAS No. 154 is effective for all fiscal years beginning after December 15, 2005.  The Company does not believe that the adoption of SFAS No. 154 will have a material impact on its consolidated financial statements.

 

ITEM 3.  Quantitative and Qualitative Disclosures About Market Risk

 

Market risk disclosure included in the Company’s fiscal year ending March 31, 2005, Form 10-K, Part II, Item 7 A, is still applicable and updated through September 30, 2005 (see Note 3 to the consolidated financial statements).

 

ITEM 4. Controls and Procedures

 

(a). The Company’s management evaluated, with the participation of the Chief Executive Officer and Chief Financial Officer, the effectiveness of the Company’s disclosure controls and procedures as of September 30, 2005. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2005, which is the end of the period covered by this report.

 

(b). During the second quarter of fiscal year 2006, there were no changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1.  Legal Proceedings

 

Other than as reported in the Company’s fiscal year ending March 31, 2005, Form 10-K under the caption “Item 3.  Legal Proceedings,” the Company is not currently a party to any material pending legal proceedings other than routine litigation incidental to the business of the Company.  The ultimate legal and financial liability of the Company with respect to such litigation cannot be estimated with any certainty.  However, in the opinion of management, based on its examination of these matters and its experience to date, the ultimate outcome of these legal proceedings, net of liabilities already accrued in the Company’s Consolidated Balance Sheets and expected insurance proceeds, is not expected to have a material adverse effect on the Company’s consolidated financial position, although the resolution in any reporting period of one or more of these matters could have a significant impact on the Company’s results of operations and cash flows for that period.

 

ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

ITEM 3.  Defaults Upon Senior Securities

 

None.

 

23



 

ITEM 4.  Submission of Matters to a Vote of Security Holders

 

None.

 

ITEM 5.  Other Information

 

None.

 

ITEM 6.  Exhibits

 

Exhibit 31.1 Rule 13a-14(a)/15d-14(a) Certification - Principal Executive Officer.

 

Exhibit 31.2 Rule 13a-14(a)/15d-14(a) Certification - Principal Financial Officer.

 

Exhibit 32.1 Section 1350 Certifications - Principal Executive Officer.

 

Exhibit 32.2 Section 1350 Certifications - Principal Financial Officer.

 

24



 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

Date: November 9, 2005

 

 

 

 

KEMET Corporation

 

 

 

 

 

/S/ David E. Gable

 

 

David E. Gable

 

Senior Vice President and
Chief Financial Officer

 

25